Meropenem Steriscience 500 mg powder for solution for injection and infusion EFG
Meropenem Steriscience 1000 mg powder for solution for injection and infusion EFG
Meropenem
Read the entire leaflet carefully before starting to use this medicine, as it contains important information for you.
Contents of the leaflet
Meropenem Steriscience contains the active substance meropenem and belongs to a group of medicines called carbapenem antibiotics. It works by killing bacteria that can cause serious infections.
Antibiotics are used to treat bacterial infections and are not effective against viral infections such as the flu or the common cold.
It is essential to follow the instructions regarding dosage, administration interval, and treatment duration indicated by your doctor.
Do not store or reuse this medicine. If you have any leftover antibiotic after completing treatment, return it to the pharmacy for proper disposal. Do not throw medicines down the drain or in the trash.
Meropenem is used to treat the following infections in adults and children over 3 months of age:
Meropenem may be used to treat patients with neutropenia who present with fever that is suspected to be due to a bacterial infection.
Meropenem can be used to treat bacterial infections of the blood that may be associated with one of the aforementioned infections.
Do not use Meropenem Steriscience:
Warnings and precautions
Consult your doctor or nurse before starting to use this medicine if:
You may test positive for a test (Coombs test) that indicates the presence of antibodies that can destroy red blood cells. Your doctor will discuss this with you.
You may experience signs and symptoms of severe skin reactions (see section 4). If this happens, inform your doctor or nurse immediately so that they can treat the symptoms.
If you are unsure whether you are in any of these situations, consult your doctor or nurse before using this medicine.
Children
This medicine is not recommended for use in children under 3 months of age, as the safety and efficacy of meropenem have not been established in children of these ages.
Other medicines and Meropenem Steriscience
Tell your doctor, pharmacist, or nurse if you are using, have recently used, or may need to use any other medicine.
This is because meropenem may affect the way some medicines work, and some of these may have an effect on meropenem.
In particular, tell your doctor, pharmacist, or nurse if you are taking any of the following medicines:
Pregnancy and breastfeeding
Pregnancy
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine. It is preferable to avoid using meropenem during pregnancy. Your doctor will decide whether you should use meropenem.
Breastfeeding
It is very important that, before receiving treatment with meropenem, you inform your doctor if you are breastfeeding or plan to breastfeed. A small amount of this medicine may pass into breast milk. Therefore, your doctor will decide whether you should use meropenem during breastfeeding.
Driving and using machines
No studies have been conducted on the effects on the ability to drive and use machines.
This medicine has been associated with headache and tingling or numbness in the skin (paresthesia). Any of these side effects could affect your ability to drive or use machines.
This medicine may cause involuntary muscle movements, which can cause the person's body to shake rapidly and uncontrollably (convulsions). This is usually accompanied by a loss of consciousness. Do not drive or use machines if you experience this side effect.
Meropenem Steriscience contains sodium
Meropenem Steriscience 500 mg: This medicine contains 45 mg of sodium (main component of table salt/cooking salt) per 500 mg dose. This is equivalent to 2.25% of the maximum daily sodium intake recommended for an adult.
Meropenem Steriscience 1000 mg: This medicine contains 90 mg of sodium (main component of table salt/cooking salt) per 1000 mg dose. This is equivalent to 4.5% of the maximum daily sodium intake recommended for an adult.
Follow the administration instructions for this medicine exactly as indicated by your doctor, pharmacist, or nurse. If in doubt, consult your doctor, pharmacist, or nurse again.
Use in adults
Use in children and adolescents
How to use Meropenem Steriscience
If you use more Meropenem Steriscience than you should
If you accidentally use more than the prescribed dose, contact your doctor or go to the nearest hospital immediately.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to use Meropenem Steriscience
If you forget an injection, you should receive it as soon as possible. However, if it is almost time for your next injection, do not receive the missed one. Do not use a double dose (two injections at the same time) to make up for missed doses.
If you stop using Meropenem Steriscience
Do not stop using meropenem until your doctor tells you to.
If you have any other doubts about using this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everyone gets them.
Severe allergic reactions
If you experience any of the following signs and symptoms, inform your doctor or nurse immediately. You may need urgent medical treatment. The signs and symptoms can include a sudden onset of any of the following:
Damage to red blood cells (frequency not known)
The symptoms include:
If you notice any of the above, go to a doctor immediately.
Other possible side effects:
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Reporting side effects
It is essential to report suspected side effects to the medicine after authorization. This allows for continuous monitoring of the benefit-risk balance of the medicine. Healthcare professionals are invited to report suspected side effects to the Spanish Medicines Monitoring System: www.notificaRAM.es.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date shown on the packaging and on the label of the vials after EXP. The expiration date is the last day of the month indicated.
This medicine does not require special storage conditions.
Injection
After reconstitution:
The reconstituted solutions for intravenous solution should be used immediately.
Chemical and physical stability in use of the solutions prepared for intravenous injection has been demonstrated for the following periods:
Infusion
After reconstitution:
The reconstituted solutions for intravenous solution should be used immediately.
When meropenem is dissolved in sodium chloride 0.9% (9 mg/ml), chemical and physical stability in use of the solutions prepared for infusion has been demonstrated for the following periods:
When meropenem is dissolved in glucose (dextrose) 5% (50 mg/ml), the solution should be used immediately.
From a microbiological point of view, unless the reconstitution method rules out the risk of microbiological contamination, the product should be used immediately.
If not used immediately, the storage times and conditions are the responsibility of the user.
Do not freeze the reconstituted solution.
Medicines should not be thrown down the drain or into the trash. Deposit the packaging and medicines you no longer need in the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
The active ingredient is meropenem.
Each vial contains meropenem trihydrate equivalent to 500 mg or 1000 mg of meropenem.
The other component is sodium carbonate.
Appearance of the product and packaging content
Meropenem Steriscience is a powder of a color that ranges from white to pale yellow for injectable solution and for infusion in a vial.
Meropenem Steriscience 500 mg powder for injectable solution and for infusion
Transparent glass vial with a bromobutyl rubber stopper sealed with an easy-to-open aluminum cap and sky blue in color.
Meropenem Steriscience 1000 mg powder for injectable solution and for infusion
Transparent glass vial with a bromobutyl rubber stopper sealed with an easy-to-open aluminum cap and red in color.
The product is available in packaging sizes of 1 or 10 vials. Only some packaging sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Steriscience B.V.
Kranenburgweg 135-A
2583 ER The Hague
Netherlands
Manufacturer
Pharma Pack Hungary Kft.
H-2040, Budaörs, Vasút út 13
Hungary
This medicinal product is authorized in the Member States of the European Economic Area under the following names:
Belgium | Meropenem Steriscience 500 mg powder for solution for injection/infusion Meropenem Steriscience 1000 mg powder for solution for injection/infusion |
Bulgaria | Meropenem 500 mg ????? ?? ???????????/?????????? ??????? Meropenem 1000 mg ????? ?? ???????????/?????????? ??????? |
Estonia | Meropenem Steriscience |
Finland | Meropenem Steriscience 500 mg injektio-/infuusiokuiva-aine liuosta varten Meropenem Steriscience 1000 mg injektio-/infuusiokuiva-aine liuosta varten |
France | Meropenem Steriscience 500 mg poudre pour solution injectable/pour perfusion Meropenem Steriscience 1000 mg poudre pour solution injectable/pour perfusion |
Netherlands | Meropenem Steriscience 500mg, poeder voor oplossing voor injectie of infusie Meropenem Steriscience 1000 mg, poeder voor oplossing voor injectie of infusie |
Croatia | Meropenem Steriscience 500 mg prašak za otopinu za injekciju/infuziju Meropenem Steriscience 1000 mg prašak za otopinu za injekciju/infuziju |
Ireland | Meropenem 500 mg powder for solution for injection/infusion Meropenem 1000 mg powder for solution for injection/infusion |
Italy | Meropenem Steriscience |
Iceland | Meropenem 500 mg stungulyfs-/innrennslisstofn, lausn Meropenem 1000 mg stungulyfs-/innrennslisstofn, lausn |
Czech Republic | Meropenem Steriscience |
Lithuania | Meropenem 500 mg milteliai injekciniam ar infuziniam tirpalui Meropenem 1000 mg milteliai injekciniam ar infuziniam tirpalui |
Latvia | Meropenem Steriscience, 500 mg pulveris injekciju/infuziju škiduma pagatavošanai Meropenem Steriscience, 1000 mg pulveris injekciju/infuziju škiduma pagatavošanai |
Luxembourg | Meropenem 500 mg Pulver fir Léisung fir Injektioun / Infusioun Meropenem 1000 mg Pulver fir Léisung fir Injektioun / Infusioun |
Hungary | Meropenem Steriscience, 500 mg por oldatos injekcióhoz vagy infúzióhoz Meropenem Steriscience, 1000 mg por oldatos injekcióhoz vagy infúzióhoz |
Malta | Meropenem Steriscience 500 mg powder for solution for injection/infusion Meropenem Steriscience 1000 mg powder for solution for injection/infusion |
Norway | Meropenem Steriscience |
Poland | Meropenem Steriscience |
Portugal | Meropenem 500 mg pó para solução injetável/perfusão Meropenem 1000 mg pó para solução injetável/perfusão |
Austria | Meropenem Steriscience 500 mg Pulver zur Herstellung einer Injektions- oder Infusionslösung Meropenem Steriscience 1000 mg Pulver zur Herstellung einer Injektions- oder Infusionslösung |
Romania | Meropenem Steriscience 500 mg pulbere pentru solutie injectabila/ perfuzabila Meropenem Steriscience 1000 mg pulbere pentru solutie injectabila/ perfuzabila |
Greece | Meropenem 500 mg κ?νις για εν?σιμο δι?λυμα / ?γχυση Meropenem 1000 mg κ?νις για εν?σιμο δι?λυμα / ?γχυση |
Cyprus | Meropenem 500 mg Κ?νις για εν?σιμο δι?λυμα/ δι?λυμα προς ?γχυση Meropenem 1000 mg Κ?νις για εν?σιμο δι?λυμα/ δι?λυμα προς ?γχυση |
Slovak Republic | Meropenem Steriscience 500 mg prášok na injekcný/ infúzny roztok Meropenem Steriscience 1000 mg prášok na injekcný/ infúzny roztok |
Denmark | Meropenem Steriscience |
Slovenia | Meropenem Steriscience 500 mg prašek za raztopino za injiciranje/infundiranje Meropenem Steriscience 1000 mg prašek za raztopino za injiciranje/infundiranje |
Spain | Meropenem Steriscience 500 mg polvo para solución inyectable y para perfusión Meropenem Steriscience 1000 mg polvo para solución inyectable y para perfusión |
Sweden | Meropenem Steriscience, 500 mg pulver till injektions-/infusionsvätska, lösning Meropenem Steriscience, 1000 mg pulver till injektions-/infusionsvätska, lösning |
Date of last revision of this leaflet:01 2022
Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.
This information is intended only for healthcare professionals:
To consult all the information on administration guidelines, warnings, and precautions, instructions for reconstitution of the medicinal product before administration, etc., see the technical data sheet.
Instructions for administering meropenem to yourself or administering it to another person at home
Some patients, parents, and caregivers are trained to administer meropenem at home.
Warning: This medicinal product should only be administered to yourself or to another person at home after a doctor or nurse has trained you.
How to prepare this medicinal product
Meropenem dose | Amount of "water for injectable preparations" needed for dilution |
500 mg (milligrams) | 10 ml (milliliters) |
1000 mg | 20 ml |
1500 mg | 30 ml |
2000 mg | 40 ml |
Note:If the amount of meropenem prescribed for you is more than 1 g, you will need to use more than one meropenem vial. You can then draw up the liquid from the vials into a syringe.
Administration of the injection
You can administer this medicinal product through a peripheral intravenous catheter, or through a port or central line.
Administration of meropenem through a peripheral intravenous catheter
Administration of meropenem through a port or central line
Each vial is for single use.
The solution must be shaken before use. Before administration, it must be visually inspected for particles or color change. Use the solution only if it is transparent and colorless or yellowish and does not contain particles.
For the storage conditions after reconstitution/dilution of the medicinal product, see section 5.
The disposal of unused medicinal product and all materials that have come into contact with it will be carried out in accordance with local regulations.